共 40 条
- [1] TISSUE-TYPE PLASMINOGEN-ACTIVATOR ANTIGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR IN DIABETES-MELLITUS [J]. ARTERIOSCLEROSIS, 1988, 8 (01): : 68 - 72
- [2] AZNAR J, 1988, BRIT HEART J, V59, P535
- [3] BACHMANN F, 1994, HAEMOSTASIS THROMBOS, P575
- [4] INCREASED FIBRIN TURNOVER AND HIGH PAI-1 ACTIVITY AS PREDICTORS OF ISCHEMIC EVENTS IN ATHEROSCLEROTIC PATIENTS - A CASE-CONTROL STUDY [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (10): : 1412 - 1417
- [6] GENETIC-VARIATION AT THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 LOCUS IS ASSOCIATED WITH ALTERED LEVELS OF PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01): : 183 - 190
- [7] DEWITT SG, 1989, ARTERIOSCLEROSIS, V9, P430
- [8] HEMOSTATIC VARIABLES IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - EFFECT OF REGULAR PLASMA-CHOLESTEROL REMOVAL BY LOW-DENSITY-LIPOPROTEIN APHERESIS [J]. ARTERIOSCLEROSIS, 1990, 10 (06): : 1119 - 1126
- [9] LEUKOCYTES AND THE RISK OF ISCHEMIC DISEASES [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (17): : 2318 - 2324
- [10] IMPACT OF WEIGHT-LOSS ON PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1), FACTOR-VII, AND OTHER HEMOSTATIC FACTORS IN MODERATELY OVERWEIGHT ADULTS [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (02): : 162 - 169